The use of percutaneous implants for the prosthetic rehabilitation of orbital defects in irradiated cancer patients: a report of clinical outcomes and complications.
This retrospective study evaluated the use of percutaneous craniofacial implants for the prosthetic rehabilitation of patients with a history of orbital exenteration and irradiation for oncologic tumors of the head and neck. A total of 24 implants were placed in six patients. All implants were determined to be osseointegrated at the time of uncovering. Three implants were subsequently resubmerged beneath the soft tissue because of positional interferences with prosthesis fabrication. The remaining 21 implants were ultimately used to retain six orbital prostheses. Two implants failed to maintain osseointegration during the follow-up period and were subsequently removed without complications. This represents an overall integration success rate of 90.5% over a mean follow-up period of 32.8 months (range = 11 to 68 months). The significance of these findings and their relationship to comparable reports in the literature are discussed.
Kosmidou
L
L
University of Chicago, Zoller Dental Clinics, Illinois 60637, USA.
Toljanic
J A
JA
Moran
W J
WJ
Panje
W R
WR
D000328:Adult; D000368:Aged; D016371:Cranial Irradiation / Q000009:adverse effects*; D005137:Eye, Artificial; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D008297:Male; D019931:Maxillofacial Prosthesis Implantation; D008875:Middle Aged; D009915:Orbit / Q000528:radiation effects* / Q000601:surgery; D016348:Osseointegration; D012189:Retrospective Studies; D016896:Treatment Outcome